Salmeterol is a long-acting beta-2 adrenergic receptor agonist (LABA) primarily used as a bronchodilator for the maintenance treatment of moderate-to-severe persistent asthma and chronic obstructive pulmonary… Read more

![Chemical structure of 1-(RS)-1-[4-Hydroxy-3-(Hydroxymethylphenyl]-2-[(4-phenylbutyl)aminoethanol-d3 (Salmeterol EP Impurity)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1-RS-1-4-Hydroxy-3-Hydroxymethylphenyl-2-4-phenylbutylaminoethanol-d3-Salmeterol-EP-Impurity.png&w=3840&q=75)











![Chemical structure of 4-Hydroxy-α1-[[[6-(2-phenylethoxy)hexyl]amino]methyl]-1,3-benzenedimethanol-d3](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F4-Hydroxy-1-6-2-phenylethoxyhexylaminomethyl-13-benzenedimethanol-d3.png&w=3840&q=75)



![Chemical structure of [6-(4-Phenylbutoxy)hexyl]benzylamine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F97664-55-6-6-4-Phenylbutoxyhexylbenzylamine.png&w=3840&q=75)




























![Chemical structure of Tert-Butyl (S)-(2-(2,2-dimethyl-4H-benzo[d][1,3]dioxin-6-yl)-2-hydroxyethyl)carbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2724154-01-0-Tert-Butyl-S-2-22-dimethyl-4H-benzod13dioxin-6-yl-2-hydroxyethylcarbamate.png&w=3840&q=75)
Salmeterol is a long-acting beta-2 adrenergic receptor agonist (LABA) primarily used as a bronchodilator for the maintenance treatment of moderate-to-severe persistent asthma and chronic obstructive pulmonary disease. To ensure therapeutic efficacy and regulatory compliance, pharmaceutical laboratories require high-quality reference standards for the parent drug, as well as its associated metabolites, degradation products, and synthesis-related impurities. These materials are essential for robust impurity profiling and accurate quantification during quality control and stability testing. Furthermore, stable isotope labelled compounds are used as internal standards in mass spectrometry to account for matrix effects and ensure precision during analytical method validation. By utilizing these characterized reference materials, researchers can effectively identify and monitor potential contaminants, ensuring that pharmaceutical products meet established safety and quality standards in alignment with international regulatory guidelines for respiratory therapeutics.